Arizona Tribune - Boulevard

NYSE - LSE

RBGPF	-3.48%	62.9	$
BCC	-0.2%	74.84	$
CMSC	0.15%	20.27	$
JRI	-2.35%	10.65	$
RELX	1.18%	33.82	$
NGG	-0.13%	76.02	$
BCE	0.05%	19.74	$
GSK	-1.03%	46.55	$
RIO	1.51%	95.65	$
CMSD	0%	20.43	$
BTI	0.45%	52.88	$
VOD	-0.18%	16.79	$
RYCEF	1.92%	19.8	$
AZN	-0.24%	156.53	$
BP	-0.38%	44.62	$

Featured

Ready, set, snooze: Sleep-deprived Japanese compete for best-rested

In diligent, exhausted Japan, self-described elite "competitive sleepers" vied to lie down, relax and nap the fastest and deepest in a contest organised by a mattress company.

Tens of thousands expected in Paris for high school protests

Tens of thousands of demonstrators are expected on the streets of Paris on Tuesday as France's powerful trade unions join high school students rallying for better conditions in a wave of protests marked by clashes with police.

Last news

Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides

SHELTON, CT / ACCESS Newswire / September 23, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that the Phase II Clinical Trial of the Company's Novel Broad-Spectrum Antiviral Drug NV-387 as a Treatment for Monkeypox Virus Infection has begun with enrollment of first patients in the Democratic Republic of Congo (DRC).

Champion Safe Launches Major Lean Transformation of Utah Factory to Increase Throughput, Lower Cost and Accelerate Dealer Fulfillment

Comprehensive factory realignment is designed to eliminate waste and bottlenecks, increase throughput, lower unit costs, shorten lead times, improve quality and delivery consistency, strengthen working-capital efficiency, and create a more scalable operating platform for converting dealer demand into shipments and revenue.

Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions

Leadership changes strengthen alignment and execution as Company advances Entolimod and evaluates strategic, commercial and government opportunities

65% of Hospital Nurses Polled Feel Watched by AI, 63% Report Added Work, Reports Black Book RN Survey

Hospital automation's hidden warning signs: Nearly half of nurses surveyed say they are likely to seek roles with less AI exposure, while one in three report less willingness to flag near misses or uncertainty.

The Longview: Fireside Chat with Biodexa CEO Stephen Stamp

Today's interview with Stephen Stamp, CEO of Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) is about the Company's lead program, eRapa in Familial Adenomatous Polyposis (FAP), a genetic disease of the lower GI tract for which the only current remedy is surgical removal of the colon and/or rectum.Key takeaways: eRapa is an oral drug candidate designed to reduce or eliminate the need for surgical treatments; a Phase 3 registrational trial, running at 29 U.S. and EU centers, is more than 50 percent enrolled; an interim futility analysis is expected in Q1 2027; FDA and EMA Orphan Drug designations are complemented by $20 million in grant funding from Texas-based CPRIT.

Warpaint London PLC Announces Interim Results

LONDON, UK / ACCESS Newswire / September 23, 2026 / Warpaint London plc (AIM:W7L)(OTCQX:WPNTF), the specialist supplier of high-quality colour cosmetics and personal care brands at an affordable price, and owner of the W7, Technic, Skin & Tan, Super Facialist, Dirty Works, Fish Soho and Barry M brands, announces its unaudited interim results for the six months ended 30 June 2026 ("H1 2026").

InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 23

LONDON, UK / ACCESS Newswire / September 23, 2026 / The Company announces that on 22 September 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.

US-led Americas coalition backs sanctions against crime groups

President Donald Trump on Tuesday urged a US-led coalition in Latin America to impose sanctions on 24 criminal networks, just hours after denouncing regional drug cartels as "the ISIS of the Western Hemisphere."

Trump renames AI 'super intelligence' as leaders jostle over dangers

President Donald Trump on Tuesday announced that the US government would rename artificial intelligence "super intelligence" in official communications, as world leaders jostled over how to address the dangers of the fast-advancing technology.

Sri Lanka hands 220-year jail terms to 15 convicted of Easter bombings

Sri Lanka’s High Court on Tuesday handed 220-year jail terms to 15 men convicted of direct involvement in the 2019 Easter Sunday bombings, which killed 279 people.

Typhoon Dujuan leaves 7 dead in Japan from landslides, flooding: media

Typhoon Dujuan left seven people dead with five others still missing Tuesday after the storm triggered landslides and flooding in the greater Tokyo area, Kyodo News reported, citing authorities.

Moldova declares energy, water emergency

Moldova's parliament on Tuesday voted to introduce a 60-day state of emergency in the energy and water sectors as the country faces rising fuel prices and a severe drought.

French Holocaust denier jailed for eight months

A Paris court on Tuesday jailed a prominent French Holocaust denier for eight months for claiming that Nazi gas chambers did not exist during World War II.

Hurricane Polo strengthens to top category 5 off Mexico

Hurricane Polo reached maximum category 5 strength off the Pacific coast of Mexico on Tuesday but is expected to stay at sea, the US National Hurricane Center (NHC) said.

Cambodia showcases scams crackdown with global conference

Cambodia showed off a shuttered scam compound complete with counterfeit cash and a fake police station this week ahead of a global conference intended to burnish its anti-fraud credentials.

Inside the Venezuelan prison meant to 'drive you insane'

Former political prisoners of Venezuela's Rodeo I are unable to shake the memories of punishments dealt out by hooded jailers in the country's most notorious prison.

Sri Lanka to issue verdict in landmark Easter attack trial

Sri Lanka is set to conclude on Tuesday the trial of 24 men accused of plotting the 2019 Easter Sunday bombings, the deadliest attack against civilians in the island's history.

SAINT BELLA Marks First Anniversary at Waldorf Astoria Monarch Beach

The anniversary event highlighted the brand's mother-centered, all-in-one approach to postpartum care.

Action Behavior Centers Launches New Career Resource Hub for BCBAs(R) and ABA Therapists

From Salary Guides to Upcoming Events, the New Career Hub Offers Resources Designed to Help BCBAs Grow Their ABA Careers

Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform

CALGARY, AB AND VANCOUVER, BC / ACCESS Newswire / September 22, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF) (Frankfurt:W1H, WKN:A3EKSZ) ("Onco") and Redwood AI Corp. (CSE:AIRX)(OTCQB:RDWCF)(Frankfurt:Y0N, WKN:A422EZ) ("Redwood AI") are pleased to announce that Onco, as lead applicant, together with Redwood AI, Canada's Michael Smith Genome Sciences Centre ("GSC") and Centre de recherche du CHU de Québec-Université Laval ("CRCHUQ"), as co-applicants, have been awarded a competitive grant under the Digital Health Innovation Fund (DHIF), administered by the Terry Fox Research Institute (TFRI), to support the development and advancement of SynoGraph, an AI-driven oncology platform being developed by Onco. Each co-applicant is an individual recipient under the grant, with the parties' respective participation and collaboration governed by the contribution agreements relating to the DHIF-funded project. Under these agreements, Redwood AI will contribute proprietary data integration and physicochemical modelling methods aimed at expanding the predictive core of SynoGraph. The DHIF award is a reimbursement-based grant for up to 25% of an estimated $3.5 million project budget.

Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results

Fourth quarter fiscal 2026 net revenue increased 6.4% to $16.1 million from $15.1 million in the prior-year quarterFourth quarter fiscal 2026 Adjusted EBITDA of $0.5 millionEXXUA net revenue of $6.6 million in fiscal 2026, including $3.9 million in the fourth quarter, following full commercial launch during third quarter fiscal 2026EXXUA fourth quarter fiscal 2026 total prescriptions were 3,323, up approximately 138% from 1,398 in third quarter fiscal 2026$26.3 million cash balance at June 30, 2026Company to host conference call and webcast today, September 22, 2026, at 4:30 p.m. Eastern time

Rezera Announces Plans to Launch the REVEAL-PAD Multi-Center Study Investigating the Role of Inflammation in Patients with Peripheral Artery Disease

AURORA, CO / ACCESS Newswire / September 22, 2026 / Rezera Inc. (the "Company"), a clinical-stage biotechnology company developing a portfolio of internally-invented and wholly-owned oral inhibitors of NLRP3 to address inflammatory drivers of cardiovascular and neurologic diseases, announced plans to launch REVEAL-PAD, a prospective, multi-center observational study to investigate the role of inflammation in peripheral artery disease (PAD) and to identify patients who may be eligible to be screened for the Company's planned Phase 3 trial of ruvonoflast in PAD.

Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist(R), Creating a Vertically Integrated Pharmaceutical Manufacturing and Distribution Platform Serving Federal, Tribal and Underserved Markets

Stateline is a DSCSA-compliant specialty pharmaceutical wholesale distributor with approximately 400 active healthcare accounts in Puerto Rico and a 50-state title model executed through third-party logistics partner DrugzoneStrategic tribal 8(a) teaming agreement gives the combined company access to set-aside and sole-source federal contracting channels, including Indian Health Service pharmaceutical supplyVICP has signed a definitive agreement to acquire NitroMist® (nitroglycerin) lingual aerosol, NDA 021780, for a US$2.0million convertible note and is preparing stability, medium-fill and pre-production batches with its contract manufacturing partner for the product's relaunchCompany in discussions to acquire an approximately 120,000-square-foot former big-pharma API manufacturing facility in Puerto Rico, including 50,000 square feet of cleanroom manufacturing space and 70,000 square feet of distribution space

Who Are the Best Facelift Surgeons in the U.S.?

The Best Facelift Surgeons in the U.S. Are Dr. Sajan and Dr. Santos

UC Berkeley SkyDeck Deepens Air & Space and Quantum Expertise Ahead of Demo Day

New track chairs Leah Walker and Claire Cramer join SkyDeck to support founders in air and space and quantum

Medical Care Technologies Inc. (OTCID:MDCE) Subsidiaries Infinite Auctions and Real Game Used Complete first transaction with Fanatics / Topps

First Game-Worn Supply Path Moves From Agreement Into Executed Sale and Photo-Match Verification

Dolphin Subsidiary 42West's 2026 Toronto International Film Festival Slate Delivered 16 Titles Including "People's Choice" Documentary Award Winner

MIAMI, FL / ACCESS Newswire / September 22, 2026 / Dolphin (NASDAQ:DLPN), a leading entertainment marketing and content production company, today announced the prominence of its subsidiary 42West at the 51st Toronto International Film Festival in Toronto, Canada. 42West has been a leader in film festival PR campaigns throughout its 21-year history, representing countless films at international and domestic festivals including Annecy, Berlin, Cannes, New York, Sundance, Telluride, Tribeca, and Venice.

Jaguar Health Receives Fee Waivers from FDA

Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and SBS for crofelemer powder for oral solution, targeting an NDA filing for MVID mid-2027

TailorMed CEO Srulik Dvorsky to Lead Panel Session at NASP InSPire 2026

Discussion Will Explore AI-Enabled Patient Automation Services in Specialty Pharmacies

Revecore Launches Legal Appeals Service to Pursue the Complex Denials Hospitals Struggle to Overturn

New offering brings attorney expertise to complex denials, including ERISA-governed appeals

Vogenx Appoints Ken Toombs to Board of Directors

Former Chief Executive Officer of PA Consulting brings three decades of global professional services and life sciences leadership experienceAppointment broadens independent oversight as the Company scales operations following its August 2026 initial public offering

Physician Cites Stemtech as "Cornerstone" Behind His Focus on STEM Cell Medicine

Dr. Zahoorudin, MBBS, M.D., a board-certified diplomate of the American Academy of Stem Cell Physicians, (AASCP) USA, credits Stemtech's stem cell nutrition science with launching his career in regenerative medicine.

Arizona Tribune - Boulevard (English)